NeoGenomics, Inc. (NASDAQNEO) Receives Consensus Recommendation of Moderate Buy from Analysts
News Source : ETF Daily News
News Summary
- NeoGenomics, Inc
- (NASDAQ:NEO) has been given an average rating of “Moderate Buy” by the eleven research firms that are covering the stock
- One analyst has rated the stock with a hold rating and ten have issued a buy rating on the company
- The average 12 month target price among brokerages that have issued ratings on the stock in the last year is $20
- 30
Shares of NeoGenomics, Inc. (NASDAQNEO Get Free Report) have been given an average rating of Moderate Buy by the eleven research firms that are covering the stock, MarketBeat.com reports. One an [+4530 chars]
-limited-logo-1200x675.png?v=20240522095703&w=240&h=240&zc=2){kind=logo}
Never miss a story from us, subscribe to our newsletter